Safety of sildenafil in premature infants at risk of bronchopulmonary dysplasia: Rationale and methods of a phase II randomized trial.
Lang JE, Hornik CD, Martz K, Jacangelo J, Anand R, Greenberg R, Hornik C, Zimmerman K, Smith PB, Benjamin DK, Laughon M; Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee.
Lang JE, et al. Among authors: jacangelo j.
Contemp Clin Trials Commun. 2022 Oct 31;30:101025. doi: 10.1016/j.conctc.2022.101025. eCollection 2022 Dec.
Contemp Clin Trials Commun. 2022.
PMID: 36345347
Free PMC article.